Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients

Saved in:
Bibliographic Details
Published in:AIDS Research and Treatment
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553593709133825
collection WordPress RSS
FRELIP Feed Integration
container_title AIDS Research and Treatment
description
discipline_display Dermatology and Venereology
discipline_facet Dermatology and Venereology
format Online Article
RSS Article
genre Journal Article
id rss_article:76628
institution FRELIP
journal_source_facet AIDS Research and Treatment
last_indexed 2026-06-20T21:38:57.850Z
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients
Dermatology and Venereology
General
Dermatology and Venereology
sub_discipline_display General
sub_discipline_facet General
subject_display Dermatology and Venereology
General
Dermatology and Venereology
subject_facet Dermatology and Venereology
General
Dermatology and Venereology
title BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients
title_alt Estudio BIKSWITCH: efectividad y seguridad del cambio a bictegravir/emtricitabina/tenofovir alafenamida (B/F/TAF) desde terapias no basadas en inhibidores de integrasa en pacientes infectados por VIH con supresión virológica
Étude BIKSWITCH : efficacité et sécurité du passage au bictegravir/emtricitabine/ténofovir alafénamide (B/F/TAF) à partir de thérapies non basées sur les inhibiteurs de l'intégrase chez les patients infectés par le VIH virologiquement supprimés
Estudo BIKSWITCH: Eficácia e Segurança da Troca para Bictegravir/Emtricitabina/Tenofovir Alafenamida (B/F/TAF) de Terapias Não Baseadas em Inibidores de Integrase em Pacientes HIV-Infectados Suprimidos Virologicamente
title_auth BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients
title_es_txt Estudio BIKSWITCH: efectividad y seguridad del cambio a bictegravir/emtricitabina/tenofovir alafenamida (B/F/TAF) desde terapias no basadas en inhibidores de integrasa en pacientes infectados por VIH con supresión virológica
title_fr_txt Étude BIKSWITCH : efficacité et sécurité du passage au bictegravir/emtricitabine/ténofovir alafénamide (B/F/TAF) à partir de thérapies non basées sur les inhibiteurs de l'intégrase chez les patients infectés par le VIH virologiquement supprimés
title_full BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients
title_fullStr BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients
title_full_unstemmed BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients
title_pt_txt Estudo BIKSWITCH: Eficácia e Segurança da Troca para Bictegravir/Emtricitabina/Tenofovir Alafenamida (B/F/TAF) de Terapias Não Baseadas em Inibidores de Integrase em Pacientes HIV-Infectados Suprimidos Virologicamente
title_short BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients
title_sort bikswitch study: effectiveness and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide (b/f/taf) from therapies not based on integrase inhibitors in virologically suppressed hiv-infected patients
topic Dermatology and Venereology
General
Dermatology and Venereology
url https://www.hindawi.com/journals/art/2025/8818830/